OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation
Shanshan Hu, X Chen, Xiangxiang Xu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 6
Shanshan Hu, X Chen, Xiangxiang Xu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 6
Showing 6 citing articles:
Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF‐β/SMAD signalling
Zhirui Zhang, Wei Wu, Hao Jiao, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 12, pp. 1562-1581
Closed Access | Times Cited: 31
Zhirui Zhang, Wei Wu, Hao Jiao, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 12, pp. 1562-1581
Closed Access | Times Cited: 31
Post‐operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A , p53, and SMAD4 expression
Yohei Masugi, Manabu Takamatsu, Mariko Tanaka, et al.
The Journal of Pathology Clinical Research (2023) Vol. 9, Iss. 5, pp. 339-353
Open Access | Times Cited: 14
Yohei Masugi, Manabu Takamatsu, Mariko Tanaka, et al.
The Journal of Pathology Clinical Research (2023) Vol. 9, Iss. 5, pp. 339-353
Open Access | Times Cited: 14
An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
Yue Chen, Tianqi Luo, Si‐Si Xu, et al.
Cancer Medicine (2021) Vol. 10, Iss. 7, pp. 2268-2285
Open Access | Times Cited: 20
Yue Chen, Tianqi Luo, Si‐Si Xu, et al.
Cancer Medicine (2021) Vol. 10, Iss. 7, pp. 2268-2285
Open Access | Times Cited: 20
Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer
Suguru Mitsufuji, Yoshifumi Iwagami, Shogo Kobayashi, et al.
Annals of Surgical Oncology (2022) Vol. 29, Iss. 8, pp. 4937-4946
Open Access | Times Cited: 9
Suguru Mitsufuji, Yoshifumi Iwagami, Shogo Kobayashi, et al.
Annals of Surgical Oncology (2022) Vol. 29, Iss. 8, pp. 4937-4946
Open Access | Times Cited: 9
Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Mariam M. Konaté, Julia Krushkal, Ming-Chung Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Mariam M. Konaté, Julia Krushkal, Ming-Chung Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
KRAS, CDKN2A, TP53, And SMAD4 Alterations in Relation to Postoperative Survival and Recurrence Patterns Among Patients with Pancreatic Cancer
Yohei Masugi, Manabu Takamatsu, Mariko Tanaka, et al.
SSRN Electronic Journal (2022)
Closed Access
Yohei Masugi, Manabu Takamatsu, Mariko Tanaka, et al.
SSRN Electronic Journal (2022)
Closed Access
